Testing effectiveness (Phase 2)Ended earlyNCT02201524What this trial is testingStudy to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisWho this might be right forPlaque Psoriasis Pfizer 59
Not applicableUnknownNCT03817164What this trial is testingEfficacy and Safety Study of Autonomic Nerve Modulation (ANM) in Subjects With Moderate Plaque PsoriasisWho this might be right forPlaque Psoriasis Thync Global, Inc. 110
Early research (Phase 1)Study completedNCT03018509What this trial is testingStudy to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis SubjectsWho this might be right forPlaque PsoriasisPsoriasisSkin Diseases Akros Pharma Inc. 47
Large-scale testing (Phase 3)Study completedNCT02052609What this trial is testingClinical Study of KHK 4827Who this might be right forPsoriasis VulgarisPsoriatic ArthritisPustular; Psoriasis, Palmaris Et Plantaris+1 more Kyowa Kirin Co., Ltd. 155
Post-approval studies (Phase 4)Study completedNCT00852761What this trial is testingEvaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type PsoriasisWho this might be right forPlaque-Type Psoriasis Stiefel, a GSK Company 34
Testing effectiveness (Phase 2)Study completedNCT01610596What this trial is testingDetermine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque PsoriasisWho this might be right forPsoriasisPlaque Psoriasis Therapeutics, Inc. 72
Large-scale testing (Phase 3)UnknownNCT01628081What this trial is testingThe Effect of Alga Dunaliella Bardawil on PsoriasisWho this might be right forPsoriasis Sheba Medical Center 46
Testing effectiveness (Phase 2)Study completedNCT01831466What this trial is testingTofacitinib Ointment For Chronic Plaque PsoriasisWho this might be right forPsoriasis VulgarisPsoriasis Pfizer 476
Early research (Phase 1)Study completedNCT03669757What this trial is testingClinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque PsoriasisWho this might be right forPsoriasis Vulgaris LEO Pharma 13
Large-scale testing (Phase 3)Study completedNCT01908595What this trial is testingLong Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque PsoriasisWho this might be right forPsoriasis Maruho North America Inc. 480
Post-approval studies (Phase 4)Study completedNCT01875991What this trial is testingPreference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With EtanerceptWho this might be right forRheumatoid ArthritisPlaque Psoriasis Amgen 217
Testing effectiveness (Phase 2)Study completedNCT01987843What this trial is testingDose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPlaque Psoriasis Tanabe Pharma Corporation 142
Testing effectiveness (Phase 2)Study completedNCT03004846What this trial is testingGSK2981278 Ointment in Subjects With Plaque PsoriasisWho this might be right forPsoriasis GlaxoSmithKline 8
Early research (Phase 1)Study completedNCT03898583What this trial is testingClinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.Who this might be right forPsoriasis Vulgaris LEO Pharma 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT07623486What this trial is testingTrial of HSK44459 Cream for the Management Plaque PsoriasisWho this might be right forPsoriasis Haisco Pharmaceutical Group Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT01096862What this trial is testingExplore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe PsoriasisWho this might be right forPsoriasis Astellas Pharma Inc 124
Early research (Phase 1)Study completedNCT03894579What this trial is testingAutologous Natural Killer Cells in Subjects With Plaque PsoriasisWho this might be right forPlaque Psoriasis NKGen Biotech, Inc. 9
Large-scale testing (Phase 3)Study completedNCT03766685What this trial is testingEvaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)Who this might be right forChronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis UCB Biopharma SRL 172
Large-scale testing (Phase 3)Study completedNCT06648772What this trial is testingEfficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 StudyWho this might be right forPlaque Psoriasis Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 190
Early research (Phase 1)Study completedNCT06143371What this trial is testingInvestigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis.Who this might be right forHealthyPlaque Psoriasis Otsuka Pharmaceutical Development & Commercialization, Inc. 80